Experts at Aaranya Biosciences use a comprehensive safety pharmacology testing services.

We’re ready to listen to you and then design just the right studies to help with the registration of novel drugs and filing Investigational New Drug (IND) applications prior to phase I studies.

We will work with you to evaluate the potential adverse effects of your compound on major organ systems, as well as to assess the QT prolongation.

 Our experts can perform core battery tests, such as studying the effects on the central nervous system, respiratory system and cardiovascular system, including cardiopulmonary safety pharmacology and also on second tier testing on renal and urinary, gastrointestinal systems and further evaluation on drug dependency.